| Country |
Population |
Age (N) |
Criteria |
MS Prevalence
(% of the population) |
| Men |
Women |
Total |
| India |
Men and Women |
20-70
(26 001) |
NCEP
IDF
WHO |
-
-
- |
-
-
- |
25,8
18,3
23,0 |
| India |
Men and Women |
>20
(1123) |
NCEP |
22,9 |
39,9 |
31,6 |
| India |
Men and Women |
20-75
(475) |
NCEP |
- |
- |
41,1 |
| Thailand |
Men and Women |
≥35
(404) |
NCEP |
- |
- |
18,0 |
| Thailand |
Men and Women |
20-70
(1383) |
NCEP |
15,7 |
11,7 |
12,8 |
| Singapore |
Men and Women |
adults
(3954) |
NCEP |
14,1 |
12,3 |
- |
| China |
Men and Women |
20-90
(16342) |
NCEP with BMI ≥ 25 Kg/m² |
15,7 |
10,2 |
13,2 |
| China |
Men and Women |
18-66
(1513) |
NCEP
IDF
WHO
NCEP |
- |
- |
9,6
7,4
13,4
5,8 |
| China |
Men and Women |
25-64
(18630) |
NCEP modified for asians
IDF |
-
- |
-
- |
9,5
8,5 |
| China |
Men and Women |
50-85
(10362) |
NCEP
IDF |
-
- |
-
- |
8,5
15,7
25,8 |
| China |
Men and Women with DMT2 |
>30 (1039) |
NCEP
IDF
WHO |
-
-
- |
-
-
- |
55,7
50,0
70,0 |
| China |
Men and Women with DMT2 |
19-95
(3589) |
NCEP |
23,9 |
12,8 |
16,8 |
| Japan |
Men and Women |
19-88 (8144) |
NCEP |
19,0 |
7,0 |
- |
| Japan |
Men and Women |
30-79 (6985) |
NCEP |
30,2 |
10,3 |
- |
| Japan |
Men and Women |
>40
(11941) |
Three or more metabolic risk factors |
- |
- |
14,9 |
NCEP = US National Cholesterol Education Program - Adult Treatment Panel III; IDF = International Diabetes Federation; WHO = World Health Organization: DMT2 =
Diabetes Mellitus type 2; BMI = body mass index. |
